Desenvolvimento de blendas de dextranos de pesos moleculares 70 e 148 KDA para a obtenção de hidrogéis contendo praziquantel

Detalhes bibliográficos
Autor(a) principal: Campos, Flávio dos Santos [UNESP]
Data de Publicação: 2013
Tipo de documento: Tese
Idioma: por
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://hdl.handle.net/11449/108793
Resumo: Schistosomiasis is a major parasitic diseases in the tropics and subtropics, caused by Schistosoma mansoni. An alternative treatment for this condition is chemotherapy, especially with praziquantel (PZQ), which is highly permeable, but has a very low solubility in water, which interferes with its bioavailability. Many strategies have been use polymers in the development of systems for controlled drug release in order to modify pharmacotechnical and biopharmaceutical properties. Amongst them, highlight the dextran hydrogels, which present various advantageous properties, some of them are: low toxicity, biocompatibility and biodegradability. In previous studies, dextran 70 (DEX-70) and 148kDa (DEX-148) hydrogels containing praziquantel had been developed by a simple, economical, of easy execution, without the use of chemical crosslinking, which generated different release profiles of drug incorporated, due swelling capacity of the hydrogels formed from each one of polymers. Based on observed in this study, the utilization of blends, which can present a major technological advantage by developing new materials with different properties, without losing its characteristics and adding their advantageous properties that can be used in the development of delivery systems, was evaluated, to provide a modulation of its pharmacotechnical and biopharmaceutical propertiesin order to develop a new technological platform in terms of systems for drug delivery. Hidrogels were characterized, employing 1H-NMR, which found an interaction between dextran and praziquantel into 1:1:1 (PZQ:DEX-70:DEX-148) hydrogel. The X-ray diffraction along with DSC showed that part of drug is dispersed in the polymer matrix in the form of crystallites, helping to improve its solubility, as evidenced by solubility studies. In in vivo studies, the sample 1:2:1 and 1:2:2, were the ones that were more effective. Finally, it was found that preparation of dextran blends containing ...
id UNSP_c386f3577219aa480496b3436a809cc6
oai_identifier_str oai:repositorio.unesp.br:11449/108793
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Desenvolvimento de blendas de dextranos de pesos moleculares 70 e 148 KDA para a obtenção de hidrogéis contendo praziquantelDextranoFarmacotécnicaEsquistossomoseBiofarmacêuticaSchistosoma mansoniSchistosomiasis is a major parasitic diseases in the tropics and subtropics, caused by Schistosoma mansoni. An alternative treatment for this condition is chemotherapy, especially with praziquantel (PZQ), which is highly permeable, but has a very low solubility in water, which interferes with its bioavailability. Many strategies have been use polymers in the development of systems for controlled drug release in order to modify pharmacotechnical and biopharmaceutical properties. Amongst them, highlight the dextran hydrogels, which present various advantageous properties, some of them are: low toxicity, biocompatibility and biodegradability. In previous studies, dextran 70 (DEX-70) and 148kDa (DEX-148) hydrogels containing praziquantel had been developed by a simple, economical, of easy execution, without the use of chemical crosslinking, which generated different release profiles of drug incorporated, due swelling capacity of the hydrogels formed from each one of polymers. Based on observed in this study, the utilization of blends, which can present a major technological advantage by developing new materials with different properties, without losing its characteristics and adding their advantageous properties that can be used in the development of delivery systems, was evaluated, to provide a modulation of its pharmacotechnical and biopharmaceutical propertiesin order to develop a new technological platform in terms of systems for drug delivery. Hidrogels were characterized, employing 1H-NMR, which found an interaction between dextran and praziquantel into 1:1:1 (PZQ:DEX-70:DEX-148) hydrogel. The X-ray diffraction along with DSC showed that part of drug is dispersed in the polymer matrix in the form of crystallites, helping to improve its solubility, as evidenced by solubility studies. In in vivo studies, the sample 1:2:1 and 1:2:2, were the ones that were more effective. Finally, it was found that preparation of dextran blends containing ...A esquistossomose é uma das principais doenças parasitárias nos trópicos e subtrópicos, causada pelo Schistosoma mansoni. Uma alternativa para o tratamento desta doença é a quimioterapia, especialmente com praziquantel (PZQ), o qual é altamente permeável, porém apresenta baixa solubilidade em água, o que interfere na sua biodisponibilidade. Muitas estratégias utilizam polímeros no desenvolvimento de sistemas de liberação de fármacos com intuito de modificar as propriedades farmacotécnicas e biofarmacêuticas. Dentre elas, destacam-se os hidrogéis de dextrano, que apresenta várias propriedades vantajosas, algumas delas são: baixa toxicidade, biocompatibilidade e biodegradabilidade. Em trabalho anterior, foram desenvolvidos hidrogéis de dextrano 70 (DEX-70) e 148kDa (DEX-148) contendo praziquantel por um método simples, econômico, de fácil execução, sem a utilização de reticulantes químicos, o que gerou perfis de liberação diferentes do fármaco incorporado, graças a capacidade de intumescimento dos hidrogéis formados com cada um dos polímeros. Com base no observado neste trabalho avaliamos a utilização de blendas, que pode apresentar uma vantagem tecnológica importante, desenvolvendo novos materiais com propriedades diferentes, sem perder suas características e agregando suas propriedades vantajosas que podem ser usadas no desenvolvimento de sistemas de liberação, para a modulação das propriedades farmacotécnicas e biofarmacêuticas, de forma a desenvolver uma nova plataforma tecnológica em termos de Sistemas de liberação de fármacos. Os hidrogéis foram caracterizados, empregando o RMN-H1, o qual constatou um interação entre dextrano e praziquantel no hidrogel 1:1:1 (PZQ:DEX-70:DEX-148). A difração de Raios-X, juntamente com o DSC, mostrou que parte do fármaco está disperso na matriz polimérica na forma de cristalitos, ajudando a melhorar sua solubilidade, como comprovado pelo estudo de ...Universidade Estadual Paulista (Unesp)Gremião, Maria Palmira Daflon [UNESP]Universidade Estadual Paulista (Unesp)Campos, Flávio dos Santos [UNESP]2014-08-13T14:50:57Z2014-08-13T14:50:57Z2013-08-29info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesis102 f : figs.application/pdfCAMPOS, Flávio dos Santos. Desenvolvimento de blendas de dextranos de pesos moleculares 70 e 148 KDA para a obtenção de hidrogéis contendo praziquantel. 2013. 102 f. Tese (doutorado) - Universidade Estadual Paulista, Faculdade de Ciências Farmacêuticas, 2013.http://hdl.handle.net/11449/108793000770166000770166.pdf33004030078P69129780536724256Alephreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPporinfo:eu-repo/semantics/openAccess2024-06-24T19:01:05Zoai:repositorio.unesp.br:11449/108793Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-06-24T19:01:05Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Desenvolvimento de blendas de dextranos de pesos moleculares 70 e 148 KDA para a obtenção de hidrogéis contendo praziquantel
title Desenvolvimento de blendas de dextranos de pesos moleculares 70 e 148 KDA para a obtenção de hidrogéis contendo praziquantel
spellingShingle Desenvolvimento de blendas de dextranos de pesos moleculares 70 e 148 KDA para a obtenção de hidrogéis contendo praziquantel
Campos, Flávio dos Santos [UNESP]
Dextrano
Farmacotécnica
Esquistossomose
Biofarmacêutica
Schistosoma mansoni
title_short Desenvolvimento de blendas de dextranos de pesos moleculares 70 e 148 KDA para a obtenção de hidrogéis contendo praziquantel
title_full Desenvolvimento de blendas de dextranos de pesos moleculares 70 e 148 KDA para a obtenção de hidrogéis contendo praziquantel
title_fullStr Desenvolvimento de blendas de dextranos de pesos moleculares 70 e 148 KDA para a obtenção de hidrogéis contendo praziquantel
title_full_unstemmed Desenvolvimento de blendas de dextranos de pesos moleculares 70 e 148 KDA para a obtenção de hidrogéis contendo praziquantel
title_sort Desenvolvimento de blendas de dextranos de pesos moleculares 70 e 148 KDA para a obtenção de hidrogéis contendo praziquantel
author Campos, Flávio dos Santos [UNESP]
author_facet Campos, Flávio dos Santos [UNESP]
author_role author
dc.contributor.none.fl_str_mv Gremião, Maria Palmira Daflon [UNESP]
Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Campos, Flávio dos Santos [UNESP]
dc.subject.por.fl_str_mv Dextrano
Farmacotécnica
Esquistossomose
Biofarmacêutica
Schistosoma mansoni
topic Dextrano
Farmacotécnica
Esquistossomose
Biofarmacêutica
Schistosoma mansoni
description Schistosomiasis is a major parasitic diseases in the tropics and subtropics, caused by Schistosoma mansoni. An alternative treatment for this condition is chemotherapy, especially with praziquantel (PZQ), which is highly permeable, but has a very low solubility in water, which interferes with its bioavailability. Many strategies have been use polymers in the development of systems for controlled drug release in order to modify pharmacotechnical and biopharmaceutical properties. Amongst them, highlight the dextran hydrogels, which present various advantageous properties, some of them are: low toxicity, biocompatibility and biodegradability. In previous studies, dextran 70 (DEX-70) and 148kDa (DEX-148) hydrogels containing praziquantel had been developed by a simple, economical, of easy execution, without the use of chemical crosslinking, which generated different release profiles of drug incorporated, due swelling capacity of the hydrogels formed from each one of polymers. Based on observed in this study, the utilization of blends, which can present a major technological advantage by developing new materials with different properties, without losing its characteristics and adding their advantageous properties that can be used in the development of delivery systems, was evaluated, to provide a modulation of its pharmacotechnical and biopharmaceutical propertiesin order to develop a new technological platform in terms of systems for drug delivery. Hidrogels were characterized, employing 1H-NMR, which found an interaction between dextran and praziquantel into 1:1:1 (PZQ:DEX-70:DEX-148) hydrogel. The X-ray diffraction along with DSC showed that part of drug is dispersed in the polymer matrix in the form of crystallites, helping to improve its solubility, as evidenced by solubility studies. In in vivo studies, the sample 1:2:1 and 1:2:2, were the ones that were more effective. Finally, it was found that preparation of dextran blends containing ...
publishDate 2013
dc.date.none.fl_str_mv 2013-08-29
2014-08-13T14:50:57Z
2014-08-13T14:50:57Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv CAMPOS, Flávio dos Santos. Desenvolvimento de blendas de dextranos de pesos moleculares 70 e 148 KDA para a obtenção de hidrogéis contendo praziquantel. 2013. 102 f. Tese (doutorado) - Universidade Estadual Paulista, Faculdade de Ciências Farmacêuticas, 2013.
http://hdl.handle.net/11449/108793
000770166
000770166.pdf
33004030078P6
9129780536724256
identifier_str_mv CAMPOS, Flávio dos Santos. Desenvolvimento de blendas de dextranos de pesos moleculares 70 e 148 KDA para a obtenção de hidrogéis contendo praziquantel. 2013. 102 f. Tese (doutorado) - Universidade Estadual Paulista, Faculdade de Ciências Farmacêuticas, 2013.
000770166
000770166.pdf
33004030078P6
9129780536724256
url http://hdl.handle.net/11449/108793
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 102 f : figs.
application/pdf
dc.publisher.none.fl_str_mv Universidade Estadual Paulista (Unesp)
publisher.none.fl_str_mv Universidade Estadual Paulista (Unesp)
dc.source.none.fl_str_mv Aleph
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1803649426346999808